Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

MXCT – maxcyte, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MXCT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/25
12:32 pm
mxct
MaxCyte (MXCT) had its price target lowered by Craig Hallum from $7.00 to $5.00. They now have a "buy" rating on the stock.
Medium Report
MaxCyte (MXCT) had its price target lowered by Craig Hallum from $7.00 to $5.00. They now have a "buy" rating on the stock.
Report
3/25
02:19 am
mxct
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook [Seeking Alpha]
Low Report
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook [Seeking Alpha]
Report
3/25
02:15 am
mxct
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low Report
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Report
3/24
11:07 pm
mxct
MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ... [Yahoo! Finance]
Low Report
MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ... [Yahoo! Finance]
Report
3/24
06:01 pm
mxct
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low Report
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Report
3/24
05:57 pm
mxct
MaxCyte Q4 Earnings Call Highlights [Yahoo! Finance]
Low Report
MaxCyte Q4 Earnings Call Highlights [Yahoo! Finance]
Report
3/24
04:13 pm
mxct
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance [Yahoo! Finance]
Low Report
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance [Yahoo! Finance]
Report
3/24
04:05 pm
mxct
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Medium Report
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Report
3/24
07:53 am
mxct
One prediction isn't enough — Why CEOs are shifting to wartime planning [Fortune]
Medium Report
One prediction isn't enough — Why CEOs are shifting to wartime planning [Fortune]
Report
3/23
08:17 am
mxct
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer [Yahoo! Finance]
Low Report
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer [Yahoo! Finance]
Report
3/23
08:05 am
mxct
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
Low Report
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
Report
3/23
01:04 am
mxct
MaxCyte (MXCT) was downgraded by Wall Street Zen from "hold" to "sell
Medium Report
MaxCyte (MXCT) was downgraded by Wall Street Zen from "hold" to "sell
Report
3/16
10:15 am
mxct
Maryland Tech Council Announces Finalists for 2026 ICON Awards [Yahoo! Finance]
Low Report
Maryland Tech Council Announces Finalists for 2026 ICON Awards [Yahoo! Finance]
Report
3/15
01:05 am
mxct
MaxCyte (MXCT) was upgraded by Wall Street Zen from "sell" to "hold".
Low Report
MaxCyte (MXCT) was upgraded by Wall Street Zen from "sell" to "hold".
Report
3/7
02:59 am
mxct
MaxCyte (MXCT) was downgraded by Wall Street Zen from "hold" to "sell
Medium Report
MaxCyte (MXCT) was downgraded by Wall Street Zen from "hold" to "sell
Report
2/25
06:02 am
mxct
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery [Yahoo! Finance]
Low Report
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery [Yahoo! Finance]
Report
2/24
08:33 am
mxct
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery [Yahoo! Finance]
Low Report
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery [Yahoo! Finance]
Report
2/24
08:05 am
mxct
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
Medium Report
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
Report
2/23
04:37 pm
mxct
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 [Yahoo! Finance]
Medium Report
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 [Yahoo! Finance]
Report
2/23
04:05 pm
mxct
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Medium Report
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Report
2/7
02:07 am
mxct
MaxCyte (NASDAQ:MXCT) was upgraded by analysts at Wall Street Zen fr
Medium Report
MaxCyte (NASDAQ:MXCT) was upgraded by analysts at Wall Street Zen fr
Report
1/12
08:27 am
mxct
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium Report
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Report
1/12
08:05 am
mxct
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
Medium Report
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
Report
1/10
01:07 am
mxct
MaxCyte (NASDAQ:MXCT) was downgraded by analysts at Wall Street Zen
Medium Report
MaxCyte (NASDAQ:MXCT) was downgraded by analysts at Wall Street Zen
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0